Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer by Anja Charlotte Lundgren Mortensen, Hanna Berglund, Mehran Hariri, Eleftherios Papalanis, Christer Malmberg, Diana Spiegelberg

Get full text

Author Correction: Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer by Anja Charlotte Lundgren Mortensen, Hanna Berglund, Mehran Hariri, Eleftherios Papalanis, Christer Malmberg, Diana Spiegelberg

Get full text

Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy by Julia Uffenorde, Mehran Hariri, Eleftherios Papalanis, Annika Staffas, Josefine Berg, Bo Stenerlöw, Hanna Berglund, Christer Malmberg, Diana Spiegelberg, Diana Spiegelberg

Get full text

In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup by Olga Sokol, Anders Tobias Frederiksen, Mateusz Sitarz, Brita Singers Sørensen, Elham Santina, Christopher Smith, John-William Warmenhoven, Marie Davídková, Anna Jelínek Michaelidesová, Irina Danilová, Oldřich Zahradníček, Amélia Maia Leite, Ludovic de Marzi, Frederic Pouzoulet, Paweł Olko, Justyna Miszczyk, Barbara Orzechowska, Eleftherios Papalanis, Mehran Hariri, Diana Spiegelberg, Bo Stenerlöw, Alexandru Dasu, Elisabeth Bodenstein, Elke Beyreuther, Jörg Pawelke, Dorothee Pfitzmann, Karen Kirkby, Nicholas Henthorn, Marco Durante

Get full text